Baker Ellis Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Baker Ellis Asset Management's LLY Position: Q1 2026 in Review
Baker Ellis Asset Management increased its Eli Lilly (LLY) stake by 0.25% in Q1 2026, buying an estimated $9.12K and bringing the position to 3,545 shares worth $3.26M. The position accounts for 0.39% of the portfolio, ranked #67.
Baker Ellis Asset Management first reported a position in LLY in Q4 2016 and has held it in 13 quarters since. The position peaked at $3.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Baker Ellis Asset Management held 3,545 shares of Eli Lilly worth $3.26M as of Q1 2026.
- Baker Ellis Asset Management bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
- Eli Lilly made up 0.39% of Baker Ellis Asset Management's portfolio in Q1 2026, its #67 holding.
- Baker Ellis Asset Management first reported a position in Eli Lilly in Q4 2016 and has held it in 13 quarters since.
- Baker Ellis Asset Management's Eli Lilly position peaked at $3.8M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Baker Ellis Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.